Differential effects of 1,25-dihydroxyvitamin D3 on cell proliferation and calcitonin gene expression.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Endocrinology

• Publication date

  1994-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO.135.5.7956923PMID 7956923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential

  2004cited by this paper
• Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3.

  1994cited by this paper
• Differential modulation of fos and jun gene expression by 1,25-dihydroxyvitamin D3.

  1993cited by this paper
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

  1993cited by this paper
• In vivo effect of 1,25‐dihydroxycholecalciferol on the proliferation and differentiation of avian chondrocytes

  1993cited by this paper
• Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.

  1993cited by this paper
• Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.

  1993cited by this paper
• Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences.

  1993cited by this paper
• Coordinate inhibition of alkaline phosphatase and type X collagen syntheses by 1,25-dihydroxyvitamin D3 in primary cultured hypertrophic chondrocytes

  1992cited by this paper
• 1,25‐dihydroxy‐vitamin‐D3 enhances antiproliferative effect and transcription of TGF‐β1 on human keratinocytes in culture

  1992cited by this paper
• myc function and regulation.

  1992cited by this paper
• Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.

  1992cited by this paper
• Function of the c‐Myc oncoprotein

  1992cited by this paper
• Newly identified actions of the vitamin D endocrine system.

  1992cited by this paper
• Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.

  1991cited by this paper
• Sequence-specific DNA binding by Myc proteins.

  1991cited by this paper
• 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.

  1991cited by this paper
• Transcriptional suppression of cellular gene expression by c-Myc

  1991cited by this paper
• A tissue-specific enhancer in the rat-calcitonin/CGRP gene is active in both neural and endocrine cell types.

  1990cited by this paper
• Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements.

  1990cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.

  1990cited by this paper
• Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium.

  1990cited by this paper
• 1,25-Dihydroxyvitamin D3 suppresses dexamethasone effects on calcitonin secretion.

  1990cited by this paper
• Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.

  1990cited by this paper
• Structure-Function Studies on Analogues of 1α,25-Dihydroxyvitamin D3: Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption

  1990cited by this paper
• Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3.

  1989cited by this paper
• A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

  1989cited by this paper
• Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.

  1989cited by this paper
• Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells.

  1989cited by this paper
• The role of the vitamin D endocrine system in health and disease.

  1989cited by this paper
• MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.

  1988cited by this paper
• Differential effects of 1 alpha,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol on the proliferation and the differentiated phenotype of rabbit costal chondrocytes in culture.

  1988cited by this paper
• Molecular characterization of daughterless, a Drosophila sex determination gene with multiple roles in development.

  1988cited by this paper
• Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.

  1988cited by this paper
• Transcriptional regulation of the c-myc protooncogene by 1,25-dihydroxyvitamin D3 in HL-60 promyelocytic leukemia cells.

  1987cited by this paper
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

  1987cited by this paper
• Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.

  1987cited by this paper
• Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells.

  1987cited by this paper
• Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma.

  1986cited by this paper
• 1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells.

  1986cited by this paper
• Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma.

  1985cited by this paper
• 1α,25‐Dihydroxy vitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro

  1985cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro.

  1985cited by this paper
• Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Calcitonin messenger RNA encodes multiple polypeptides in a single precursor.

  1981cited by this paper
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980cited by this paper

• Vitamin D3 Treatment Alters Thyroid Functional Morphology in Orchidectomized Rat Model of Osteoporosis

  2022cites this paper
• Medullary thyroid cancer is associated with high serum vitamin D level and polymorphism of vitamin D receptors.

  2020cites this paper
• Overview of vitamin D actions in cancer

  2018cites this paper
• Association of vitamin D levels and receptor gene polymorphisms with medullary thyroid cancer

  2016cites this paper
• ارتباط بین سطح سرمی ویتامین D و پلیمورفیسمهای گیرنده آن با سرطان مدولاری تیرویید

  2016cites this paper
• Vitamin D and thyroid disease: to D or not to D?

  2014cites this paper
• The relation between disease activity, vitamin D levels and bone mineral density in men patients with ankylosing spondylitis

  2013cites this paper
• Vitamin D and Cancer

  2012cites this paper
• Vitamin D: Cancer and differentiation

  2011cites this paper
• VITAMIN D DEFICIENCY CAUSES MUSCULOSKELETAL HYPERSENSITIVITY: THE ROLE OF NOCICEPTOR HYPERINNERVATION

  2011cites this paper
• The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis

  2009cites this paper
• Vitamin D Control of the Calcitonin Gene in Thyroid C Cells

  2005cites this paper
• CHAPTER 89 – Vitamin D: Cancer and Differentiation

  2005cites this paper
• Vitamin D: Biology, Actions, and Clinical Implications

  2001cites this paper
• Relationship Between Disease Activity and Serum Levels of Vitamin D Metabolites and Parathyroid Hormone in Ankylosing Spondylitis

  2001cites this paper
• Relationship Between Disease Activity and Serum Levels of Vitamin D Metabolites and PTH in Rheumatoid Arthritis

  1998cites this paper
• Crucial role of c-myc in 1,25(OH)2D3 control of C-cell-carcinoma proliferation.

  1995cites this paper